Remicade Is TNF Blocker:
Drugs Similar to Remicade:
Remicade uses human and mouse proteins to create a chimeric monoclonal antibody. Enbrel is derived by introducing human DNA into Chinese hamster ovary cells and creating a genetically engineered protein. Humira uses fully human proteins and phage display technology to produce monoclonal antibodies.
Administration of Remicade:
Indications for Remicade:
Other conditions which have benefited from Remicade infusions include:
Recommended Dose of Remicade:
Special Concerns or Contraindications for Remicade:
Some patients can develop autoantibodies following treatment with Remicade. The autoantibodies can develop into a lupus-like condition, but it is rare.
Common Side Effects Associated with Remicade:
Serious Adverse Reactions Associated With Remicade:
- Patients on Remicade may have a higher risk of developing cancer or lymphoma. People with rheumatoid arthritis have a higher risk of lymphoma, making it hard to determine which is directly responsible.
- People on Remicade may develop a demyelinating disorder (multiple sclerosis), but this is rare.
- Remicade should not be used by congestive heart failure patients.
- Remicade can cause an infusion reaction in some patients (itching, chills, flushing, low blood pressure etc.)
Discontinuation of Remicade:
Arthritis Without Pain, Scott J. Zashin, M.D., 2004
Arthritis - A Cleveland Clinic Guide, John D. Clough, M.D., 2006
The Pill Book, 10th Edition
Remicade - Patient Information Leaflet